Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus

Judith Gledhill; Stewart Barker; CHRISTINE WANLESS; J. P. Hinson; J.R. Puddefoot; C Panahy; A W Goode; Gavin P. Vinson

doi:10.1016/0960-0760(92)90163-d

Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus

Judith Gledhill, Stewart Barker, CHRISTINE WANLESS, J. P. Hinson, J.R. Puddefoot, C Panahy, A W Goode, Gavin P. Vinson

In: The Journal of Steroid Biochemistry and Molecular Biology · 1992 · vol. 43(4) , pp. 289–296 · doi:10.1016/0960-0760(92)90163-d · PMID:1390280 · W2064163634

article OA: closed CC0 ⤵ 3 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

Danazol was investigated for its ability to induce progesterone receptor in cultured cancer cells and the rat uterus.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (42)

456 Dynamics of the receptor interactions of danazol and gestrinone in the rat. Correlation with biological activities via openalex
A controlled trial of danazol in the treatment of multiple recurrent breast cysts. via openalex
Antigonadotropin (danazol) in the treatment of endometriosis via openalex
CLINICAL EXPERIENCE OF DRUG TREATMENTS FOR MASTALGIA via openalex
Clinical Studies with an Antigonadotropin-Danazol via openalex
CONTROLLED TRIAL OF THE ANTIGONADOTROPIN DANAZOL IN PAINFUL NODULAR BENIGN BREAST DISEASE via openalex
Danazol--a steroid derivative with multiple and diverse biological effects. via openalex
Danazol binding and translocation of steroid receptors via openalex
Danazol effects on gowadotrop in basal levels and pituitary responsiveness to lh-rn in immature male rats via openalex
Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex
Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex via openalex
Danazol treatment of advanced breast cancer. via openalex
Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease. via openalex
Endocrine effects of danazol in the treatment of endometriosis via openalex
Free testosterone levels during danazol therapy via openalex
Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors via openalex
Increased Accumulation of Estrogen Receptors in Pituitary Nuclei of Danazol Treated Rats via openalex
Medical Management of Endometriosis via openalex
Medical Therapy for Endometriosis: Endocrine Pharmacology via openalex
Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component* via openalex
The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. via openalex
Treatment of breast cancer with danazol. via openalex
doi:10.1210/mend-3-9-1377 via openalex
W2728670972 via openalex
doi:10.1016/c2013-0-03841-8 via openalex
doi:10.1111/j.1742-1241.1986.tb08004.x via openalex
W6643992471 via openalex
W6715917656 via openalex
W6740218123 via openalex
doi:10.1016/s0021-9258(19)52451-6 via openalex
doi:10.1016/s0015-0282(16)43869-0 via openalex
doi:10.1007/978-1-4613-1903-0 via openalex
doi:10.1089/dna.1983.2.329 via openalex
doi:10.1021/jm00337a001 via openalex
doi:10.1073/pnas.83.8.2496 via openalex
doi:10.1210/mend-4-6-821 via openalex
doi:10.1016/s0140-6736(76)92632-5 via openalex
W2146066013 via openalex
doi:10.1007/978-1-4613-1903-0_10 via openalex
doi:10.1159/000181303 via openalex
doi:10.1016/s0015-0282(16)59727-1 via openalex

Cited by (3)

Source provenance

openalex: last seen: 2026-05-11T05:40:41.230350+00:00

License: CC0 · commercial use OK

[1] 456 Dynamics of the receptor interactions of danazol and gestrinone in the rat. Correlation with biological activities via openalex

[2] A controlled trial of danazol in the treatment of multiple recurrent breast cysts. via openalex

[3] Antigonadotropin (danazol) in the treatment of endometriosis via openalex

[4] CLINICAL EXPERIENCE OF DRUG TREATMENTS FOR MASTALGIA via openalex

[5] Clinical Studies with an Antigonadotropin-Danazol via openalex

[6] CONTROLLED TRIAL OF THE ANTIGONADOTROPIN DANAZOL IN PAINFUL NODULAR BENIGN BREAST DISEASE via openalex

[7] Danazol--a steroid derivative with multiple and diverse biological effects. via openalex

[8] Danazol binding and translocation of steroid receptors via openalex

[9] Danazol effects on gowadotrop in basal levels and pituitary responsiveness to lh-rn in immature male rats via openalex

[10] Danazol inhibition of steroidogenesis in the human corpus luteum. via openalex

[11] Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex via openalex

[12] Danazol treatment of advanced breast cancer. via openalex

[13] Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease. via openalex

[14] Endocrine effects of danazol in the treatment of endometriosis via openalex

[15] Free testosterone levels during danazol therapy via openalex

[16] Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors via openalex

[17] Increased Accumulation of Estrogen Receptors in Pituitary Nuclei of Danazol Treated Rats via openalex

[18] Medical Management of Endometriosis via openalex

[19] Medical Therapy for Endometriosis: Endocrine Pharmacology via openalex

[20] Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex

[21] Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component* via openalex

[22] The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. via openalex

[23] Treatment of breast cancer with danazol. via openalex

[24] doi:10.1210/mend-3-9-1377 via openalex

[25] W2728670972 via openalex

[26] doi:10.1016/c2013-0-03841-8 via openalex

[27] doi:10.1111/j.1742-1241.1986.tb08004.x via openalex

[28] W6643992471 via openalex

[29] W6715917656 via openalex

[30] W6740218123 via openalex

[31] doi:10.1016/s0021-9258(19)52451-6 via openalex

[32] doi:10.1016/s0015-0282(16)43869-0 via openalex

[33] doi:10.1007/978-1-4613-1903-0 via openalex

[34] doi:10.1089/dna.1983.2.329 via openalex

[35] doi:10.1021/jm00337a001 via openalex

[36] doi:10.1073/pnas.83.8.2496 via openalex

[37] doi:10.1210/mend-4-6-821 via openalex

[38] doi:10.1016/s0140-6736(76)92632-5 via openalex

[39] W2146066013 via openalex

[40] doi:10.1007/978-1-4613-1903-0_10 via openalex

[41] doi:10.1159/000181303 via openalex

[42] doi:10.1016/s0015-0282(16)59727-1 via openalex